0001096906-14-000772.txt : 20140605 0001096906-14-000772.hdr.sgml : 20140605 20140605122756 ACCESSION NUMBER: 0001096906-14-000772 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20140605 DATE AS OF CHANGE: 20140605 EFFECTIVENESS DATE: 20140605 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SignPath Pharma, Inc. CENTRAL INDEX KEY: 0001455694 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 205079533 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-193763 FILM NUMBER: 14893016 BUSINESS ADDRESS: STREET 1: 1375 CALIFORNIA ROAD CITY: QUAKERTOWN STATE: PA ZIP: 18951 BUSINESS PHONE: 267-772-0107 MAIL ADDRESS: STREET 1: 1375 CALIFORNIA ROAD CITY: QUAKERTOWN STATE: PA ZIP: 18951 D/A 1 primary_doc.xml X0707 D/A LIVE 0001455694 SignPath Pharma, Inc. 1375 CALIFORNIA ROAD QUAKERTOWN PA PENNSYLVANIA 18951 215-538-9996 DELAWARE None None Corporation true Lawrence D. Helson 1375 California Road Quakertown PA PENNSYLVANIA 18591 Executive Officer Director Pharmaceuticals No Revenues 06b true 0001096906-13-000369 2013-03-13 true true true false 100000 Meyers Associates, L.P. 34171 Bruce Meyers 34171 45 Broadway New York NY NEW YORK 10006 All States false 5000000 4355500 644500 false 14 500000 true 0 Meyers & Associates, L.P. will receive commissions of 10% per unit (except 5% on units sold to investors introduced by management) and receive warrants to purchase up to 20% of the units sold in this Offering. 204000 false SignPath Pharma, Inc. /s/ Lawrence Helson, MD Lawrence Helson, MD CEO & President 2014-06-05